Ceftazidime and Humalog drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ceftazidime (ceftazidime) and Humalog (insulin lispro recombinant). Common drug interactions include abscess among females and pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Ceftazidime and Humalog. It is created by eHealthMe based on reports of 86 people who take the same drugs from the FDA, and is updated regularly.

What is Ceftazidime?

Ceftazidime has active ingredients of ceftazidime. eHealthMe is studying from 10,327 Ceftazidime users. Check the latest studies of Ceftazidime.

What is Humalog?

Humalog has active ingredients of insulin lispro recombinant. It is often used in diabetes. eHealthMe is studying from 137,127 Humalog users. Check the latest studies of Humalog.

On Jul, 14, 2026

86 people who take Ceftazidime and Humalog together, and have interactions are studied.

Ceftazidime and Humalog drug interactions.

What are the common drug interactions of Ceftazidime and Humalog, by gender? *:

female:

Abscess (pus)
Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
Alanine aminotransferase increased
Blood alkaline phosphatase increased
Blood bilirubin increased
Blood pressure increased
Depression
Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
Endometrial disorder
Enterococcus test positive

male:

Pneumonia
Dyspnoea (difficult or laboured respiration)
Cough
Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
Respiratory failure (inadequate gas exchange by the respiratory system)
Bronchitis chronic (inflammation of the mucous membrane in the bronchial tubes- chronic)
Tachycardia (a heart rate that exceeds the range of 100 beats/min)
Weight decreased
Acidosis (build-up of carbon dioxide in the blood)
Acute respiratory distress syndrome

What are the common drug interactions of Ceftazidime and Humalog, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
Hypotension (abnormally low blood pressure)
Pneumonia
Sepsis (a severe blood infection that can lead to organ failure and death)
Acute respiratory failure
Ascites (accumulation of fluid in the abdominal cavity)
Bacterial infection
Basal ganglia infarction (disruption of the blood flow in the small blood vessels in the white matter of the cerebral cortex)
Bradycardia (abnormally slow heart action)
Cholangitis (infection of the bile duct)

20-29:

Abortion spontaneous (naturally occurring miscarriage)
Asthenia (weakness)
Complications of maternal exposure to therapeutic drugs
Drug hypersensitivity
Dyspnoea (difficult or laboured respiration)
Genital disorder female (diseases of female genital tract)
Hyperhidrosis (abnormally increased sweating)
Implant site infection
Insulin resistance
Oxygen saturation decreased

30-39:

Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
Constipation
Insomnia (sleeplessness)
Leukocytosis (increased white blood cells)
Dyspnoea (difficult or laboured respiration)
Glucose tolerance impaired (blood glucose is raised beyond normal levels, but not high enough to warrant a diabetes diagnosis)
Pneumonia
Pyrexia (fever)
Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
Respiratory failure (inadequate gas exchange by the respiratory system)

40-49:

Hallucinations, mixed (sensations that appear real but are created by your mind -mixed)
Myoclonus (a brief, involuntary twitching of a muscle or a group of muscles)
Paranoia (psychotic disorder characterized by delusions of persecution with or without grandeur)
Tardive dyskinesia (a disorder that involves involuntary movements)
Pyrexia (fever)
Abortion spontaneous (naturally occurring miscarriage)
Blood glucose decreased
Blood glucose increased
Insulin resistance
Pseudomonas infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa)

50-59:

Bone lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries)
Breath odour
Cellulitis (infection under the skin)
Cholecystitis (infection of gallbladder)
Decreased appetite
Dehydration (dryness resulting from the removal of water)
Dental caries
Erythema (redness of the skin)
Gait disturbance
Herpes zoster

60+:

Asthenia (weakness)
Pneumonia
Depression
Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
Endometrial disorder
Enterococcus test positive
Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
Gamma-glutamyltransferase increased
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Heart rate increased

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 26 people, 30.23%
Enterococcal Infection: 26 people, 30.23%
Generalised Oedema (swelling all over the body): 25 people, 29.07%
Cystic Fibrosis (disease of the secretary glands): 25 people, 29.07%
Pain: 15 people, 17.44%
Infective Pulmonary Exacerbation Of Cystic Fibrosis (severe infective lung disease with production of abnormally thick mucus): 15 people, 17.44%
Asthma: 14 people, 16.28%
High Blood Pressure: 14 people, 16.28%
Rickets (softening of bones): 12 people, 13.95%
Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 10 people, 11.63%

* Approximation only. Some reports may have incomplete information.

Do you take Ceftazidime and Humalog?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously